<DOC>
	<DOCNO>NCT00358917</DOCNO>
	<brief_summary>The purpose study compare safety , tolerability , antiviral activity once-daily ( QD ) twice-daily ( BID ) dose lopinavir/ritonavir ( LPV/r ) tablet formulation combination nucleoside/nucleotide reverse transcriptase inhibitor ( NRTIs ) antiretroviral-experienced human immunodeficiency virus type 1 infected subject detectable viral load receive current antiretroviral therapy .</brief_summary>
	<brief_title>Study Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>Subjects human immunodeficiency virus type 1 ( HIV1 ) positive , antiretroviralexperienced adult least 18 year age currently receive antiretroviral regimen change least 12 week . Subjects plasma HIV1 ribonucleic acid ( RNA ) level &gt; 1,000 copies/mL screen acutely ill. Subject currently fail his/her antiretroviral regimen recent 2 consecutive prestudy plasma HIV1 RNA level &gt; 400 copies/mL recent &gt; 1000 copies/mL , investigator 's opinion , change therapy Female subject nonpregnant nonlactating . Subjects exclude screen laboratory analysis show hemoglobin &lt; = 8.0 gram per deciliter . Subjects exclude screen laboratory analysis show absolute neutrophil count &lt; = 750 cells/microliter . Subjects exclude screen laboratory analysis show platelet count &lt; = 50,000 per cubic millimeter . Subjects exclude screen laboratory analysis show alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) &gt; = 5.0 x upper limit normal ( ULN ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>